PLANO, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Katapult Holdings, Inc. ("Katapult” or the "Company”) (NASDAQ: KPLT), an ...

Clearside's ocular oncology partner, Aura Biosciences, is enrolling patients in its global Phase 3 CoMpass trial evaluating belzupacap sarotalocan (bel-sar) for the first-line treatment of adult ...

Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner's New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema ...

GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway and clinical sites confirmed  Additional data evaluating GEO-CM04S1 as ...

A 24-year-old Australian man could go to jail for ten years as he prepares to plead guilty for importing plutonium from a US-based science website.